Skip to main content
HYPR logo

HYPR · Hyperfine, Inc.

$0.93 -0.05 (-5.19%) At close · Jul 17
Market Cap
$92.39M
Shares
99.27M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$13.56M +5.2%
FY2025 Revenue FY2020–FY2025
Net Income
-$35.57M +12.6%
FY2025 Net Income FY2020–FY2025
Gross Margin
49.79% +4.1pp
FY2025 Gross Margin FY2020–FY2025
Operating Margin
-273.43% +61.9pp
FY2025 Operating Margin FY2020–FY2025
Diluted EPS
-$0.43 +23.2%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-$27.95M +27.9%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
$20M – $22M $15.33M $13.56M $12.89M $11.03M $6.81M $1.5M $294K
$7.48M $6.81M $7M $6.28M $5.91M $2.66M $771K
$7.85M $6.75M $5.89M $4.76M $907K -$1.17M -$477K
49.79% 45.7% 43.12% 13.31% -78.01% -162.24%
$16.26M $17.45M $22.5M $22.49M $28.16M $25.84M $14.59M
$10.16M $10.13M $9.12M $10.1M $14.22M $10.36M $2.5M
$16.18M $16.25M $17.49M $20.28M $32.41M $27.5M $5.92M
$1.02M $726K $289K
$42.59M $43.84M $49.12M $52.87M $74.78M $63.7M $23.01M
-$34.74M -$37.09M -$43.22M -$48.12M -$73.87M -$64.87M -$23.49M
-273.43% -335.33% -436.14% -1084.15% -4336.1% -7990.14%
-$72.86M -$64.14M -$23.2M
$960K $1.02M $2.49M $3.84M $761K $18K $70K
$119K -$337K $12K $35K -$51K -$1000 -$6000
-$34.78M -$35.57M -$40.72M -$44.24M -$73.16M -$64.85M -$23.43M
$0 $0 $0 $0 $0 $0
-$34.78M -$35.57M -$40.72M -$44.24M -$44.24M -$64.85M -$23.43M
-262.29% -315.9% -401% -649.22% -4334.96% -7968.37%
USD/shares -$0.43 -$0.56 -$0.62 -$1.04 -$17.57
USD/shares -$0.43 -$0.56 -$0.62 -$1.04 -$17.57
shares 81.8M 72.41M 71.32M 70.45M 3.69M 1.52M
shares 81.8M 72.41M 71.32M 70.45M 3.69M 1.52M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
4.22×
Medical Devices median 2.19×
EV/EBIT
Medical Devices median 21.50×
P/E (TTM)
Medical Devices median 27.84×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31
Non Us $3,152,000 $6,394,000 $4,362,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Product $11,398,000 $10,450,000 $8,746,000 $5,246,000 $715,000 $200,000
Service $2,165,000 $2,440,000 $2,286,000 $1,568,000 $781,000 $94,000
Key facts CIK 1833769 CUSIP 44916K106 13F (30d) 2 filings 2 filers Visit website Investor relations